- Home
- Automated
- List of product information
- SKINOREN CREAM 20% [SIN07138P]
SKINOREN CREAM 20% [SIN07138P]
Active ingredients: SKINOREN CREAM 20%
Product Info
SKINOREN CREAM 20%
[SIN07138P]
Product information
Active Ingredient and Strength | AZELAIC ACID - 20 G/100 G |
Dosage Form | CREAM |
Manufacturer and Country | LEO PHARMA MANUFACTURING ITALY S.R.I. - ITALY |
Registration Number | SIN07138P |
Licence Holder | DKSH SINGAPORE PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | D10AX03 |
Indications
Treatment of acne vulgaris.
Dosage and administration
Cutaneous use
Skinoren cream should be applied to the affected areas of skin twice a day (morning and evening) and rubbed in gently. The amount of Skinoren cream to be applied will depend on the size of the affected area. As a guide, a daily dose of approximately 2.5cm/1inch of cream is sufficient for the entire facial area. Before Skinoren cream is applied, the skin should be thoroughly cleaned with clear water, or if applicable, a mild skin-cleansing agent. It is important to continue to use Skinoren cream regularly over the entire period of treatment. The duration of use of Skinoren cream can vary from patient to patient and also depends on the severity of the acne. In patients with acne, in general, a distinct improvement becomes apparent after about 4 weeks. To obtain the best results, however, Skinoren should be used regularly over several months. However, Skinoren should not be used continuously for more than 12 months at any time. In the event of excessive irritation of the skin (see “Side effects” – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information), the amount of cream per application should be reduced or the frequency of use of Skinoren cream should be reduced to once a day until the irritation ceases, or the treatment should be temporarily interrupted for a few days.
Pediatric population
Dose adjustment is not required when Skinoren cream is administered to adolescents aged 12–18 years of age. The safety and efficacy of Skinoren cream in children below the age of 12 years have not been established.
Contraindications
Hypersensitivity to the active substance or to any of the excipients of the cream, in particular propylene glycol.
